CDRH Launches ‘Health Of Women’ Program; Research Agenda To Focus On Ortho, Cardio Devices
This article was originally published in The Gray Sheet
Executive Summary
The device center plans to develop a research roadmap to explore sex-based differences in outcomes to musculoskeletal and cardiovascular disease devices, as well as devices targeting diseases specific to women. CDRH launched the effort as part of its new “Health of Women” initiative at a workshop last week.
You may also be interested in...
Products Lacking Good Subgroup Data Shouldn’t Be Approved, Patient, Medical Groups Tell FDA
FDA should more strongly enforce requirements for adequate demographic subgroup representation in clinical trials for devices and other medical products, participants said at an April 1 meeting on collection and analysis of clinical trial subpopulation data to support product registration.
Regulatory Briefs: FDA Issues Demographic Subgroups Report, Warns About Oxygen Systems
FDA released a report calling for public input on how it collects demographic subgroup data. Agency warns about misbranded hyperbaric oxygen therapy systems. More regulatory news.
Breast Implant Makers Can Use Registries To Fulfill Post-Market Surveillance Duties
After years of struggling to track breast implant patients with post-market surveillance surveys, silicone gel breast implant makers will be allowed by FDA to substitute data from two new registries to fulfill their duties on post-approval studies and device tracking, an FDA epidemiologist said recently.